시장보고서
상품코드
1184069

세계의 게노믹스 시장(2023-2027년)

Global Genomics Market 2023-2027

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 163 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

게노믹스 시장 규모는 2022-2027년간 182억 4,434만 달러 확대되고, 예측 기간중 연평균 복합 성장률(CAGR)은 10.53%를 나타낼 것으로 예측됩니다.

게노믹스(Genomics) 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인과 과제, 약 25개 벤더를 대상으로 한 벤더 분석 정보를 제공합니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 : 2022년
  • 시장 전망 : 2022-2027년 예측

제4장 시장 규모 실적

  • 세계의 게노믹스 시장(2017-2021년)
  • 솔루션 부문 분석(2017-2021년)
  • 용도 부문 분석(2017-2021년)
  • 지역 부문 분석(2017-2021년)
  • 국가 부문 분석(2017-2021년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 솔루션별 시장 세분화

  • 시장 부문
  • 솔루션별 비교
  • 제품 : 시장 규모와 예측(2022-2027년)
  • 서비스 : 시장 규모와 예측(2022-2027년)
  • 솔루션별 시장 기회

제7장 용도별 시장 세분화

  • 시장 부문
  • 용도별 비교
  • 진단 : 시장 규모와 예측(2022-2027년)
  • Drug Discovery : 시장 규모와 예측(2022-2027년)
  • 기타 : 시장 규모와 예측(2022-2027년)
  • 용도별 시장 기회

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2022-2027년)
  • 유럽 : 시장 규모와 예측(2022-2027년)
  • 아시아 : 시장 규모와 예측(2022-2027년)
  • 기타 지역(ROW) : 시장 규모와 예측(2022-2027년)
  • 미국 : 시장 규모와 예측(2022-2027년)
  • 중국 : 시장 규모와 예측(2022-2027년)
  • 영국 : 시장 규모와 예측(2022-2027년)
  • 독일 : 시장 규모와 예측(2022-2027년)
  • 프랑스 : 시장 규모와 예측(2022-2027년)
  • 지역 상황별 시장 기회

제10장 시장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 시장 성장 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • 10X Genomics Inc.
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Eppendorf SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California Inc.
  • QIAGEN NV
  • Standard BioTools Inc.

제13장 부록

LSH 23.01.20

Technavio has been monitoring the genomics market and is forecast to grow by $18244.34 mn during 2022-2027, accelerating at a CAGR of 10.53% during the forecast period. Our report on the genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomics research and development, reduction in the cost of genetic sequencing, and increasing demand for creating and upgrading genome databases.

Technavio's genomics market is segmented as below:

By Solution

  • Products
  • Services

By Application

  • Diagnostic
  • Drug discovery
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing adoption of single cell-based genomics analysis as one of the prime reasons driving the genomics market growth during the next few years. Also, advances in sequencing technologies and growing developments in precision medicine and gene therapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the genomics market covers the following areas:

  • Genomics market sizing
  • Genomics market forecast
  • Genomics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market vendors that include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and Perkin Elmer Inc. Also, the genomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Solution
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global genomics market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global genomics market 2017 - 2021 ($ million)
  • 4.2 Solution Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
  • 4.3 Application Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Solution

  • 6.1 Market segments
  • Exhibit 30: Chart on Solution - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Solution - Market share 2022-2027 (%)
  • 6.2 Comparison by Solution
  • Exhibit 32: Chart on Comparison by Solution
  • Exhibit 33: Data Table on Comparison by Solution
  • 6.3 Products - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Products - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Products - Year-over-year growth 2022-2027 (%)
  • 6.4 Services - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Services - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Services - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Solution
  • Exhibit 42: Market opportunity by Solution ($ million)

7 Market Segmentation by Application

  • 7.1 Market segments
  • Exhibit 43: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application
  • Exhibit 45: Chart on Comparison by Application
  • Exhibit 46: Data Table on Comparison by Application
  • 7.3 Diagnostic - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
  • 7.4 Drug discovery - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
  • 7.5 Others - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Application
  • Exhibit 59: Market opportunity by Application ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 France - Market size and forecast 2022-2027
  • Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 107: Matrix on vendor position and classification
  • 12.3 10X Genomics Inc.
  • Exhibit 108: 10X Genomics Inc. - Overview
  • Exhibit 109: 10X Genomics Inc. - Product / Service
  • Exhibit 110: 10X Genomics Inc. - Key offerings
  • 12.4 Abcam plc
  • Exhibit 111: Abcam plc - Overview
  • Exhibit 112: Abcam plc - Product / Service
  • Exhibit 113: Abcam plc - Key news
  • Exhibit 114: Abcam plc - Key offerings
  • 12.5 Agilent Technologies Inc.
  • Exhibit 115: Agilent Technologies Inc. - Overview
  • Exhibit 116: Agilent Technologies Inc. - Business segments
  • Exhibit 117: Agilent Technologies Inc. - Key news
  • Exhibit 118: Agilent Technologies Inc. - Key offerings
  • Exhibit 119: Agilent Technologies Inc. - Segment focus
  • 12.6 Becton Dickinson and Co.
  • Exhibit 120: Becton Dickinson and Co. - Overview
  • Exhibit 121: Becton Dickinson and Co. - Business segments
  • Exhibit 122: Becton Dickinson and Co. - Key news
  • Exhibit 123: Becton Dickinson and Co. - Key offerings
  • Exhibit 124: Becton Dickinson and Co. - Segment focus
  • 12.7 BGI Genomics Co. Ltd.
  • Exhibit 125: BGI Genomics Co. Ltd. - Overview
  • Exhibit 126: BGI Genomics Co. Ltd. - Product / Service
  • Exhibit 127: BGI Genomics Co. Ltd. - Key offerings
  • 12.8 Bio Rad Laboratories Inc.
  • Exhibit 128: Bio Rad Laboratories Inc. - Overview
  • Exhibit 129: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 130: Bio Rad Laboratories Inc. - Key news
  • Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
  • 12.9 Danaher Corp.
  • Exhibit 133: Danaher Corp. - Overview
  • Exhibit 134: Danaher Corp. - Business segments
  • Exhibit 135: Danaher Corp. - Key news
  • Exhibit 136: Danaher Corp. - Key offerings
  • Exhibit 137: Danaher Corp. - Segment focus
  • 12.10 Eppendorf SE
  • Exhibit 138: Eppendorf SE - Overview
  • Exhibit 139: Eppendorf SE - Product / Service
  • Exhibit 140: Eppendorf SE - Key news
  • Exhibit 141: Eppendorf SE - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 Illumina Inc.
  • Exhibit 147: Illumina Inc. - Overview
  • Exhibit 148: Illumina Inc. - Business segments
  • Exhibit 149: Illumina Inc. - Key news
  • Exhibit 150: Illumina Inc. - Key offerings
  • Exhibit 151: Illumina Inc. - Segment focus
  • 12.13 Myriad Genetics Inc.
  • Exhibit 152: Myriad Genetics Inc. - Overview
  • Exhibit 153: Myriad Genetics Inc. - Product / Service
  • Exhibit 154: Myriad Genetics Inc. - Key offerings
  • 12.14 Oxford Nanopore Technologies plc
  • Exhibit 155: Oxford Nanopore Technologies plc - Overview
  • Exhibit 156: Oxford Nanopore Technologies plc - Product / Service
  • Exhibit 157: Oxford Nanopore Technologies plc - Key offerings
  • 12.15 Pacific Biosciences of California Inc.
  • Exhibit 158: Pacific Biosciences of California Inc. - Overview
  • Exhibit 159: Pacific Biosciences of California Inc. - Product / Service
  • Exhibit 160: Pacific Biosciences of California Inc. - Key offerings
  • 12.16 QIAGEN NV
  • Exhibit 161: QIAGEN NV - Overview
  • Exhibit 162: QIAGEN NV - Product / Service
  • Exhibit 163: QIAGEN NV - Key news
  • Exhibit 164: QIAGEN NV - Key offerings
  • 12.17 Standard BioTools Inc.
  • Exhibit 165: Standard BioTools Inc. - Overview
  • Exhibit 166: Standard BioTools Inc. - Product / Service
  • Exhibit 167: Standard BioTools Inc. - Key news
  • Exhibit 168: Standard BioTools Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 169: Inclusions checklist
  • Exhibit 170: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 171: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 172: Research methodology
  • Exhibit 173: Validation techniques employed for market sizing
  • Exhibit 174: Information sources
  • 13.5 List of abbreviations
  • Exhibit 175: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제